Recent

2 December 2019

Fidia Introduces in the US the 3-injection regimen TRILURON™ (sodium hyaluronate)

Fidia Introduces in the US the 3-injection regimen TRILURON

12 April 2019

Fidia Pharma USA Inc Announces Expansion into the Dietary Supplement Market with Launch of CartiJoint™ FORTE

CartiJoint™ FORTE is the First Product in Fidia’s New Dietary Supplement Portfolio; Uniquely formulated with bioactive Bio-Curcumin Curcugreen™

12 March 2019

Fidia Pharma USA Inc Announces Expansion into Regenerative Medicine Markets with Launch of NuDYN™

Florham Park, NJ, March 12, 2019 – NuDYN™ is the First Product in Fidia’s New Orthobiologics Portfolio; A Novel Acellular Amnion-Derived Injectable Allograft

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness